drugset / Trial / NCT01511757

Bioavailability Study of Fluconazole Tablets 200 mg Under Fed Conditions

NCT01511757

Phase 1 Completed 15 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of this study was an open-label, randomized, 2-way crossover to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Pfizer (Diflucan®) 200 mg fluconazole tablets under fed conditions.

Timeline

Start
2002-06
Primary completion
2002-06
Completion
2002-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluconazole Small molecule 200 mg Oral

Indications

No indication recorded.